Published in Infect Immun on July 01, 2000
Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother (2008) 2.02
Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun (2004) 1.82
Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Infect Immun (2003) 1.82
Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Infect Immun (2002) 1.76
Association of linear plasmid 28-1 with an arthritic phenotype of Borrelia burgdorferi. Infect Immun (2005) 1.30
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med (2007) 1.29
Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids. PLoS One (2012) 1.28
Constitutive expression of outer surface protein C diminishes the ability of Borrelia burgdorferi to evade specific humoral immunity. Infect Immun (2006) 1.28
Differential detection of five mouse-infecting helicobacter species by multiplex PCR. Clin Diagn Lab Immunol (2005) 1.20
Analysis of an ordered, comprehensive STM mutant library in infectious Borrelia burgdorferi: insights into the genes required for mouse infectivity. PLoS One (2012) 1.19
Antibody-mediated disease remission in the mouse model of lyme borreliosis. Infect Immun (2006) 1.17
The fur homologue in Borrelia burgdorferi. J Bacteriol (2004) 1.11
Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity. PLoS One (2008) 1.05
Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease. Infect Immun (2005) 1.04
Gamma interferon is not required for arthritis resistance in the murine Lyme disease model. Infect Immun (2001) 1.02
Characterization of unique regions of Borrelia burgdorferi surface-located membrane protein 1. Infect Immun (2010) 1.00
Dissociation of infectivity and pathogenicity in Borrelia burgdorferi. Infect Immun (2001) 0.99
Lymphoadenopathy during lyme borreliosis is caused by spirochete migration-induced specific B cell activation. PLoS Pathog (2011) 0.98
Quantitative analysis of Borrelia burgdorferi gene expression in naturally (tick) infected mouse strains. Med Microbiol Immunol (2005) 0.98
Immunogenicity of Borrelia burgdorferi arthritis-related protein. Infect Immun (2003) 0.97
Lyme arthritis: current concepts and a change in paradigm. Clin Vaccine Immunol (2007) 0.94
Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies. Infect Immun (2001) 0.94
The failure of immune response evasion by linear plasmid 28-1-deficient Borrelia burgdorferi is attributable to persistent expression of an outer surface protein. Infect Immun (2008) 0.93
Human Lyme arthritis and the immunoglobulin G antibody response to the 37-kilodalton arthritis-related protein of Borrelia burgdorferi. Infect Immun (2005) 0.93
Cloning and expression of a Helicobacter bilis immunoreactive protein. Clin Diagn Lab Immunol (2002) 0.85
Humoral immune response associated with lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins. Clin Diagn Lab Immunol (2002) 0.83
Influence of arthritis-related protein (BBF01) on infectivity of Borrelia burgdorferi B31. BMC Microbiol (2013) 0.81
Presence of Arp specifically contributes to joint tissue edema associated with early-onset Lyme arthritis. Infect Immun (2013) 0.78
CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection. Infect Immun (2014) 0.78
Plasmid diversity and phylogenetic consistency in the Lyme disease agent Borrelia burgdorferi. BMC Genomics (2017) 0.75
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature (1997) 19.08
Lyme disease. N Engl J Med (1989) 14.06
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A (1995) 9.93
Western blotting in the serodiagnosis of Lyme disease. J Infect Dis (1993) 6.45
Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 6.36
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med (1996) 5.46
Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun (1995) 4.68
Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol (1993) 3.82
Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun (1994) 3.59
Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci U S A (1995) 3.42
Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infect Immun (1995) 3.00
Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect Immun (1995) 2.86
A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection. Infect Immun (1994) 2.74
Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis (1994) 2.72
Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol (1998) 2.68
Borrelia burgdorferi erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria. Infect Immun (1998) 2.67
Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J Immunol (1991) 2.61
Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol (1996) 2.43
Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity (1997) 2.38
Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect Immun (1998) 2.29
Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr Purif (1990) 2.23
Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis. Infect Immun (1998) 2.23
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest (1997) 2.13
Arthropod- and host-specific gene expression by Borrelia burgdorferi. J Clin Invest (1997) 2.05
DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect Immun (1998) 1.99
Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun (1993) 1.95
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93
Molecular and evolutionary analysis of Borrelia burgdorferi 297 circular plasmid-encoded lipoproteins with OspE- and OspF-like leader peptides. Infect Immun (1999) 1.84
Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Infect Immun (1998) 1.80
Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection. Infect Immun (2000) 1.75
Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis (1997) 1.74
Serum-mediated resolution of Lyme arthritis in mice. Lab Invest (1996) 1.68
Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J Infect Dis (1998) 1.52
Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci U S A (1997) 1.50
Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Mol Microbiol (1999) 1.50
Molecular and evolutionary characterization of the cp32/18 family of supercoiled plasmids in Borrelia burgdorferi 297. Infect Immun (2000) 1.38
Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species. Infect Immun (1999) 1.05
The Borrelia burgdorferi 37-kilodalton immunoblot band (P37) used in serodiagnosis of early lyme disease is the flaA gene product. J Clin Microbiol (1999) 0.98
Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science (1990) 7.33
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med (1996) 5.46
Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci U S A (1995) 3.42
Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect Immun (1992) 3.04
Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci U S A (1992) 2.99
Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis (1994) 2.72
Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg (1992) 2.57
Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. J Immunol (1992) 2.49
Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect Immun (1994) 2.42
Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity (1997) 2.38
Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice. J Infect Dis (1991) 2.37
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest (1997) 2.13
Transmissible murine colonic hyperplasia. Vet Pathol (1978) 2.11
The ultrastructure of transmissible murine colonic hyperplasia. Am J Pathol (1979) 2.11
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11
Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J Infect Dis (1994) 2.09
The etiology of transmissible murine colonic hyperplasia. Lab Anim Sci (1976) 1.98
Detection of Borrelia burgdorferi infection in Ixodes dammini ticks with the polymerase chain reaction. J Clin Microbiol (1990) 1.96
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93
Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B. Proc Natl Acad Sci U S A (1993) 1.84
Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Infect Immun (1998) 1.80
Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am J Trop Med Hyg (1990) 1.77
Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol (2000) 1.76
Long-term protection of mice from Lyme disease by vaccination with OspA. Infect Immun (1992) 1.75
Diverse Lyme disease spirochetes bind integrin alpha IIb beta 3 on human platelets. Infect Immun (1994) 1.71
The early humoral response in human granulocytic ehrlichiosis. J Infect Dis (1997) 1.67
Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol (1998) 1.64
Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol (2000) 1.63
Infectious but nonpathogenic isolate of Borrelia burgdorferi. J Clin Microbiol (1990) 1.63
T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun (2000) 1.60
Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab Anim Sci (1977) 1.60
Experimental chronic Lyme borreliosis in Lewis rats. Am J Trop Med Hyg (1990) 1.59
Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice. Infect Immun (1994) 1.57
Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest (1997) 1.56
Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Infect Immun (2000) 1.53
Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J Infect Dis (1998) 1.52
Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies. Lab Anim Sci (1998) 1.51
T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun (1997) 1.51
Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Mol Microbiol (1999) 1.50
Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J Clin Invest (1996) 1.42
Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res (1977) 1.40
Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo. J Infect Dis (1991) 1.40
OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect Immun (1993) 1.39
Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis (1998) 1.37
The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci (1993) 1.37
Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. Proc Natl Acad Sci U S A (1991) 1.36
Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans. J Clin Microbiol (1996) 1.31
Expression and sequence of outer surface protein C among North American isolates of Borrelia burgdorferi. FEMS Microbiol Lett (1994) 1.29
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun (2001) 1.26
Mouse hepatitis virus strain--related patterns of tissue tropism in suckling mice. Arch Virol (1984) 1.25
Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. J Exp Med (1993) 1.23
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
The putative E5 open reading frame of cottontail rabbit papillomavirus is dispensable for papilloma formation in domestic rabbits. J Virol (1992) 1.18
CD4+ T helper 1 cells facilitate regression of murine Lyme carditis. Infect Immun (2001) 1.17
Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. J Infect Dis (1998) 1.17
Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse. Infect Immun (1993) 1.17
Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol (2000) 1.16
Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J Infect Dis (1991) 1.14
Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice. Antimicrob Agents Chemother (1994) 1.11
Spontaneous wasting disease in nude mice associated with Pneumocystis carinii infection. Lab Anim Sci (1986) 1.11
Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J Immunol (1996) 1.10
Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. J Immunol (1997) 1.09
PTSD symptoms in Bosnian refugees 1 year after resettlement in the United States. Am J Psychiatry (1998) 1.09
Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. J Exp Med (1995) 1.07
A case of peritonitis due to Rothia mucilaginosa. Perit Dial Int (2010) 1.05
Autoradiographic cytokinetics of colonic mucosal hyperplasia in mice. Cancer Res (1979) 1.04
Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis virus JHM. Virus Res (1987) 1.03
Genetic stability of Borrelia burgdorferi recovered from chronically infected immunocompetent mice. Infect Immun (1994) 1.03
Canine neonatal deaths associated with group B streptococcal septicemia. J Am Vet Med Assoc (1983) 1.02
Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway. Infect Immun (1998) 1.02
Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation. Infect Immun (1993) 1.02
Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice. J Immunol (1993) 1.01
Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue. Res Microbiol (1997) 1.01
Atypical warts in cattle. J Am Vet Med Assoc (1974) 1.01
Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype. Arch Virol (1986) 1.00
Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B. Infect Immun (1995) 1.00
Dissociation of infectivity and pathogenicity in Borrelia burgdorferi. Infect Immun (2001) 0.99
Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice. Infect Immun (1997) 0.98
Acquisition dynamics of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis at the host-vector interface. Vector Borne Zoonotic Dis (2001) 0.97
The microbiology of transmissible murine colonic hyperplasia. Lab Anim Sci (1980) 0.96
Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination. J Immunol (2001) 0.95
Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infect Immun (1995) 0.95
Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis. J Infect Dis (2001) 0.95
The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch Virol (1991) 0.95
Mouse hepatitis virus S in weanling Swiss mice following intranasal inoculation. Lab Anim Sci (1983) 0.95
Animal models for Lyme disease. Lab Invest (1995) 0.94
Epizootic coronaviral typhlocolitis in suckling mice. Lab Anim Sci (1982) 0.93
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis. Infect Immun (1997) 0.92
Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation. J Infect Dis (2001) 0.91
Dexamethasone-induced cytokine changes associated with diminished disease severity in horses infected with Anaplasma phagocytophilum. Clin Vaccine Immunol (2011) 0.89
Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis. Ann Neurol (2001) 0.89
Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice. J Immunol (1996) 0.89
Evaluation of diagnostic methods for Helicobacter bilis infection in laboratory mice. Comp Med (2001) 0.89